Ignite Creation Date:
2024-05-05 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00391066
Status:
TERMINATED
Last Update Posted:
2015-10-02
First Post:
2006-10-19
Brief Title:
Lumiliximab With Fludarabine Cyclophosphamide and Rituximab FCR Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia CLL
Sponsor:
Biogen
Organization:
Biogen
Organization Data
Organization:
Biogen
Class:
INDUSTRY
Study ID:
152CL201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Biogen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None